Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

We report on manufacturing outcomes for 41 autologous polyclonal regulatory T cell (PolyTreg) products for 7 different Phase 1 clinical trials over a 10-year period (2011-2020). Data on patient characteristics, manufacturing parameters, and manufacturing outcomes were collected from manufacturing ba...

Full description

Bibliographic Details
Main Authors: Joanna Balcerek, Brian R. Shy, Amy L. Putnam, Lisa M. Masiello, Angela Lares, Florinna Dekovic, Luis Acevedo, Michael R. Lee, Vinh Nguyen, Weihong Liu, Sreenivasan Paruthiyil, Jingying Xu, Ashley S. Leinbach, Jeffrey A. Bluestone, Qizhi Tang, Jonathan H. Esensten
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
regulatory T cell manufacturing
cGMP
ex vivo expansion
cellular therapy
regulatory T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.744763/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.744763/full

Similar Items